NCT04309578 2024-02-28
A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC
Asan Medical Center
Phase 2 Unknown
Asan Medical Center
QureBio Ltd.
The Netherlands Cancer Institute
Dong-A University Hospital
Alaunos Therapeutics